News
Treating coronary artery disease patients with monotherapy using clopidogrel or ticagrelor was associated with lower rates of ...
An investigation has uncovered evidence of significant misreporting, raising new concerns about the approval and long-term ...
In a follow up investigation into the multibillion dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in key platelet studies used in its FDA approval.
In a follow up investigation into the multibillion dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in key platelet studies used in its FDA approval. For more than a decade, ...
The twice-daily pill is given to people with acute coronary syndrome -a sudden reduction of blood to the heart-reducing the ...
Hosted on MSN26d
Top medics issue warning over heart drug - AstraZeneca accused of 'misreporting' dataAnti-clotting pill ticagrelor was approved for use on the NHS in 2011 after trials claimed it could prevent one in five deaths after a heart attack. The twice-daily pill, sold as Brilinta, is given to ...
In a follow-up investigation into the multibillion-dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in key platelet studies used in its FDA approval.
Two leaders of some of the largest labor unions in the country say they are leaving the Democratic National Committee (DNC), citing disagreements with the committee's leadership over its future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results